If you feel your concerns are not being adequately addressed, you have the right to request a second opinion or referral to a specialist diabetes service
Every ingredient is identity tested, and every finished product undergoes heavy metal and microbial testing prior to release
SURMOUNT-5 Trial Overview SURMOUNT-5 (NCT05822830) is a multicenter, randomized, open-label Phase 3b trial aimed at assessing the efficacy and safety of Zepbound (tirzepatide) compared to Wegovy (semaglutide) in adults with obesity or overweight, with at least one comorbidity (such as hypertension, dyslipidemia, obstructive sleep apnea (OSA), or cardiovascular disease), and no diabetes
Under these guidelines, the default BUD for a sterile compounded preparation stored under refrigeration is relatively conservative unless the pharmacy has conducted extended stability testing on their specific formulation
For more on GI side effects during treatment, our article on semaglutide side effects long term offers additional context
These FDA-approved medications help control appetite, improve metabolism, and support long-term weight management